Amneal Pharmaceuticals, Inc.
Recent Filings
All 642 filings →| Form | Description | Date |
|---|---|---|
| 4/A | FORM 4/A | Mar 27, 2026 |
| 4/A | FORM 4/A | Mar 27, 2026 |
| SCHEDULE 13D/A | — | Mar 26, 2026 |
| SCHEDULE 13G/A | — | Mar 26, 2026 |
| DEFA14A | DEFINITIVE ADDITIONAL PROXY SOLICITING MATERIALS | Mar 25, 2026 |
| DEF 14A | DEFINITIVE PROXY STATEMENT | Mar 25, 2026 |
| 4 | FORM 4 | Mar 5, 2026 |
| 4 | FORM 4 | Mar 5, 2026 |
| 4 | FORM 4 | Mar 5, 2026 |
| 4 | FORM 4 | Mar 5, 2026 |
Insider Transactions
View all →| Insider | Title | Type | Shares | Owns After | Date |
|---|---|---|---|---|---|
| Nark Ted C | — | Sale | 50,000 @ $11.72 | 291,029 | Nov 17, 2025 |
| Shah Nikita | Executive Vice President | Sale | 131,856 @ $11.92 | 146,403 | Nov 12, 2025 |
| Kiely John | — | Sale | 32,000 @ $9.23 | 225,433 | Aug 27, 2025 |
| Shah Nikita | Executive Vice President | Sale | 114,492 @ $9.66 | 152,743 | Aug 25, 2025 |
| BOYER ANDREW S | Executive Vice President | Sale | 279,244 @ $9.38 | 152,426 | Aug 20, 2025 |
| Konidaris Tasos | Executive Vice President & CFO | Sale | 161,365 @ $9.22 | 460,517 | Aug 15, 2025 |
| Shah Nikita | Executive Vice President | Sale | 71,694 @ $9.29 | 267,235 | Aug 14, 2025 |
| Shah Nikita | Executive Vice President | Sale | 50,000 @ $9.04 | 338,929 | Aug 12, 2025 |
| Daly Jason B. | EVP, Chief Legal Officer | Sale | 22,000 @ $9.05 | 10,606 | Aug 12, 2025 |
| BOYER ANDREW S | Executive Vice President | Sale | 33,436 @ $9.05 | 256,670 | Aug 12, 2025 |